Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort

Diabetologia
Henna CederbergMarkku Laakso

Abstract

The aim of this work was to investigate the mechanisms underlying the risk of type 2 diabetes associated with statin treatment in the population-based Metabolic Syndrome in Men (METSIM) cohort. A total of 8,749 non-diabetic participants, aged 45-73 years, were followed up for 5.9 years. New diabetes was diagnosed in 625 men by means of an OGTT, HbA1c ≥6.5% (48 mmol/mol) or glucose-lowering medication started during the follow-up. Insulin sensitivity and secretion were evaluated with OGTT-derived indices. Participants on statin treatment (N = 2,142) had a 46% increased risk of type 2 diabetes (adjusted HR 1.46 [95% CI 1.22, 1.74]). The risk was dose dependent for simvastatin and atorvastatin. Statin treatment significantly increased 2 h glucose (2hPG) and glucose AUC of an OGTT at follow-up, with a nominally significant increase in fasting plasma glucose (FPG). Insulin sensitivity was decreased by 24% and insulin secretion by 12% in individuals on statin treatment (at FPG and 2hPG <5.0 mmol/l) compared with individuals without statin treatment (p < 0.01). Decreases in insulin sensitivity and insulin secretion were dose dependent for simvastatin and atorvastatin. Statin treatment increased the risk of type 2 diabetes by 46%, attr...Continue Reading

References

Sep 1, 2005·European Journal of Clinical Investigation·E ter AvestA F H Stalenhoef
Dec 29, 2006·Journal of Atherosclerosis and Thrombosis·Mayumi IshikawaHitoshi Shimano
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Feb 4, 2009·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Rishi SukhijaJawahar L Mehta
Oct 2, 2009·Diabetes Care·Swapnil N RajpathakPaul M Ridker
Nov 17, 2009·Diabetes Research and Clinical Practice·William L BakerCraig I Coleman
Apr 2, 2011·Journal of the American College of Cardiology·David D WatersPhilip Barter
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
Jan 11, 2012·Archives of Internal Medicine·Annie L CulverYunsheng Ma
Jul 24, 2012·Atherosclerosis. Supplements·Naveed Sattar, Marja-Riitta Taskinen
Aug 1, 2012·British Journal of Clinical Pharmacology·Nur Lisa ZaharanKathleen Bennett
Aug 14, 2012·Journal of the American College of Cardiology·Kang-Ling WangChern-En Chiang
Jan 29, 2013·The American Journal of Cardiology·Eliano Pio NavareseJacek Kubica
May 25, 2013·BMJ : British Medical Journal·Aleesa A CarterMuhammad M Mamdani

❮ Previous
Next ❯

Citations

Nov 13, 2015·Expert Opinion on Pharmacotherapy·Maria-Corina SerbanDimitri P Mikhailidis
Oct 6, 2015·Expert Opinion on Drug Safety·Aris P AgouridisMoses S Elisaf
Nov 26, 2015·Diabetes Research and Clinical Practice·Magnus Thorsten JensenJan Skov Jensen
Jan 5, 2016·European Heart Journal·M John ChapmanUlf Landmesser
Dec 17, 2015·Nature Reviews. Endocrinology·D John Betteridge, Rafael Carmena
Apr 9, 2016·Journal of Clinical Lipidology·Fotios BarkasEvangelos C Rizos
Oct 2, 2015·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kiyoto Motojima
Oct 7, 2015·Clinical Pharmacology and Therapeutics·U AnyanwaguRichard Donnelly
Jun 10, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Concetta IraceAgostino Gnasso
Aug 12, 2015·Journal of Internal Medicine·A VuorioP T Kovanen
May 28, 2015·Clinical Pharmacology and Therapeutics·S G Terra, J Vincent
Jun 1, 2015·Diabetologia·Michael S KostapanosMoses S Elisaf
Aug 21, 2015·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Pedro Marques da Silva
Apr 21, 2016·Advanced Healthcare Materials·Patrick K BowenJaroslaw W Drelich
May 31, 2016·Journal of Diabetes and Its Complications·Rahul ChaudharyPaul Gurbel
Aug 16, 2016·Diabetes Research and Clinical Practice·Gianluca BardiniEdoardo Mannucci
Nov 14, 2015·Diabetes & Metabolism Journal·Klaus G Parhofer
Aug 25, 2016·Basic & Clinical Pharmacology & Toxicology·Melina SadigharaJalal Pourahmad
Nov 11, 2016·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Valentina ScattoliniGian Paolo Fadini
Oct 28, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Thatiany de Souza MarinhoCarlos A Mandarim-de-Lacerda
Jul 22, 2016·PloS One·Huanhuan HuUNKNOWN Japan Epidemiology Collaboration on Occupational Health Study Group
Nov 13, 2015·PloS One·Nagendra YaluriMarkku Laakso
Nov 28, 2016·Scottish Medical Journal·José Pedro L Nunes
Dec 23, 2016·Gerontology & Geriatric Medicine·Kyle R Fluegge
May 31, 2017·Annals of Neurology·Henna MartiskainenMikko Hiltunen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.